Chris joined Camber in February 2024 and helps governments, funders, and international health agencies work in partnership to expand access to vaccines and life-saving medicines. He brings more than eight years of strategy consulting experience across London and San Francisco, specializing in the operating models and partnerships that turn shared ambitions into coordinated action. His strength is connecting the science with the systems needed to deliver it.
Chris began his career as a research scientist, working as a Postdoctoral Research Associate in molecular neuroscience. He holds a PhD in molecular cell biology from University College London and a BA in Physiological Sciences from the University of Oxford. Outside of work, Chris enjoys flower arranging, swimming, and adventures with his new puppy, Ollie.